Abstract
Intraductal papillary neoplasm of the bile duct (IPNB) is a heterogeneous disease similar to intraductal papillary mucinous neoplasm of the pancreas. These lesions have been recognized as one of the three major precancerous lesions in the biliary tract since 2010. In 2018, Japanese and Korean pathologists reached a consensus, classifying IPNBs into type l and type 2 IPNBs. IPNBs are more prevalent in male patients in East Asia and are closely related to diseases such as cholelithiasis and schistosomiasis. From a molecular genetic perspective, IPNBs exhibit early genetic variations, and different molecular pathways may be involved in the tumorigenesis of type 1 and type 2 IPNBs. The histological subtypes of IPNBs include gastric, intestinal, pancreaticobiliary, or oncocytic subtypes, but type 1 IPNBs typically exhibit more regular and well-organized histological features than type 2 IPNBs and are more commonly found in the intrahepatic bile ducts with abundant mucin. Due to the rarity of these lesions and the absence of specific clinical and laboratory features, imaging is crucial for the preoperative diagnosis of IPNB, with local bile duct dilation and growth along the bile ducts being the main imaging features. Surgical resection remains the optimal treatment for IPNBs, but negative bile duct margins and the removal of lymph nodes in the hepatic hilum significantly improve the postoperative survival rates for patients with IPNBs.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Cattell RB, Braasch JW, Kahn F. Polypoid epithelial tumors of the bile ducts. N Engl J Med, 1962,266:57–61
Schriefers KH. Contribution on tumors of the bile ducts (Report on papillomatosis of the extra and intrahepatic bile ducts). Zentralblatt fur Chirurgie, 1960,85:2308–2311
Kim HJ, Kim MH, Lee SK, et al. Mucin-hypersecreting bile duct tumor characterized by a striking homology with an intraductal papillary mucinous tumor (IPMT) of the pancreas. Endoscopy, 2000,32(5):389–393
Zen Y, Sasaki M, Fujii T, et al. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct—an immunohistochemical study of 110 cases of hepatolithiasis. J Hepatol, 2006,44(2):350–358
Chen TC, Nakanuma Y, Zen Y, et al. Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology, 2001,34(4 Pt 1):651–658
Suh KS, Roh HR, Koh YT, et al. Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma. Hepatology, 2000,31(1):12–17
Minagawa N, Sato N, Mori Y, et al. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes. Eur J Surg Oncol, 2013,39(6):554–558
Barton JG, Barrett DA, Maricevich MA. Intraductal papillary mucinous neoplasm of the biliary tract: a real disease? HPB (Oxford), 2009,11(8):684–691
Zen Y, Fujii T, Itatsu K, et al. Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas. Hepatology, 2006,44(5):1333–1343
Nakanuma Y. A novel approach to biliary tract pathology based on similarities to pancreatic counterparts: is the biliary tract an incomplete pancreas? Pathol Int, 2010,60(6):419–429
Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. World Health Organization. 2010
Nakanuma Y, Jang KT, Fukushima N, et al. A statement by the Japan-Korea expert pathologists for future clinicopathological and molecular analyses toward consensus building of intraductal papillary neoplasm of the bile duct through several opinions at the present stage. J Hepatobiliary Pancreat Sci, 2018,25(3):181–187
Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology, 2020,76(2):182–188
Wu RS, Liao WJ, Ma JS, et al. Epidemiology and outcome of individuals with intraductal papillary neoplasms of the bile duct. World J Gastrointest Oncol, 2023,15(5):843–857
Nakanuma Y, Uesaka K, Kakuda Y, et al. Intraductal Papillary Neoplasm of Bile Duct: Updated Clinicopathological Characteristics and Molecular and Genetic Alterations. J Clin Med, 2020,9(12):3991
Lendvai G, Szekerczes T, Illyes I, et al. Cholangiocarcinoma: Classification, Histopathology and Molecular Carcinogenesis. Pathol Oncol Res, 2020,26(1):3–15
Kanji ZS, Rocha FG. Premalignant Lesions of the Biliary Tract. Surg Clin North Am, 2019,99(2):301–314
Park HJ, Kim SY, Kim HJ, et al. Intraductal Papillary Neoplasm of the Bile Duct: Clinical, Imaging, and Pathologic Features. AJR Am J Roentgenol, 2018,211(1):67–75
Jang KT, Hong SM, Lee KT, et al. Intraductal papillary neoplasm of the bile duct associated with Clonorchis sinensis infection. Virchows Archiv, 2008,453(6):589–598
Kubo S, Nakanuma Y, Takemura S, et al. Case series of 17 patients with cholangiocarcinoma among young adult workers of a printing company in Japan. J Hepatobiliary Pancreat Sci, 2014,21(7):479–488
Kubo S, Tanaka S, Kinoshita M, et al. Development of intraductal papillary neoplasm of the bile duct in patients with occupational cholangiocarcinoma. Virchows Archiv, 2023,482(4):745–753
Aoki Y, Mizuma M, Hata T, et al. Intraductal papillary neoplasms of the bile duct consist of two distinct types specifically associated with clinicopathological features and molecular phenotypes. J Pathol, 2020,251(1):38–48
Yang CY, Huang WJ, Tsai JH, et al. Targeted next-generation sequencing identifies distinct clinicopathologic and molecular entities of intraductal papillary neoplasms of the bile duct. Mod Pathol, 2019,32(11):1637–1645
Xian ZH, Qin C, Cong WM. KRAS mutation and immunohistochemical profile in intraductal papillary neoplasm of the intrahepatic bile ducts. Pathol Res Pract, 2018,214(1):105–111
Goeppert B, Stichel D, Toth R, et al. Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis. Gut, 2022,71(2):391–401
Tomita H, Tanaka K, Hirata A, et al. Inhibition of FGF10-ERK signal activation suppresses intraductal papillary neoplasm of the bile duct and its associated carcinomas. Cell Rep, 2021,34(8):108772
Tanaka M, Shibahara J, Ishikawa S, et al. EVI1 expression is associated with aggressive behavior in intrahepatic cholangiocarcinoma. Virchows Archiv, 2019,474(1):39–46
Sato Y, Kinoshita M, Takemura S, et al. The PD-1/PD-L1 axis may be aberrantly activated in occupational cholangiocarcinoma. Pathol Int, 2017,67(3):163–170
Nakanuma Y, Uesaka K, Okamura Y, et al. Reappraisal of pathological features of intraductal papillary neoplasm of bile duct with respect to the type 1 and 2 subclassifications. Hum Pathol, 2021,111:21–35
Onoe S, Ebata T, Yokoyama Y, et al. A clinicopathological reappraisal of intraductal papillary neoplasm of the bile duct (IPNB): a continuous spectrum with papillary cholangiocarcinoma in 181 curatively resected cases. HPB (Oxford), 2021,23(10):1525–1532
Sasaki M, Matsubara T, Nitta T, et al. GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct. PLoS One, 2013,8(12):e81706
Maleki F, Rezazadeh F, Varmira K. MUC1-Targeted Radiopharmaceuticals in Cancer Imaging and Therapy. Mol Pharm, 2021,18(5):1842–1861
Fabris L, Sato K, Alpini G, et al. The Tumor Microenvironment in Cholangiocarcinoma Progression. Hepatology, 2021,73(S1):75–85
Kim JR, Jang KT, Jang JY, et al. Clinicopathologic analysis of intraductal papillary neoplasm of bile duct: Korean multicenter cohort study. HPB (Oxford), 2020,22(8):1139–1148
Gordon-Weeks AN, Jones K, Harriss E, et al. Systematic Review and Meta-analysis of Current Experience in Treating IPNB. Ann Surg, 2016,263(4):656–663
Kubota K, Jang JY, Nakanuma Y, et al. Clinicopathological characteristics of intraductal papillary neoplasm of the bile duct: a Japan-Korea collaborative study. J Hepato-biliary Pancreat Sci, 2020,27(9):581–597
Wan XS, Xu YY, Qian JY, et al. Intraductal papillary neoplasm of the bile duct. World J Gastroenterol, 2013,19(46):8595–8604
Zheng Q, Ruan SM, Shan QY, et al. Clinicopathological findings and imaging features of intraductal papillary neoplasm of the bile duct: comparison between contrast-enhanced ultrasound and contrast-enhanced computed tomography. Abdom Radiol (NY), 2019,44(7):2409–2417
Zen Y, Fujii T, Itatsu K, et al. Biliary cystic tumors with bile duct communication: a cystic variant of intraductal papillary neoplasm of the bile duct. Mod Pathol, 2006,19(9):1243–1254
Liu LN, Xu HX, Zheng SG, et al. Ultrasound Findings of Intraductal Papillary Neoplasm in Bile Duct and the Added Value of Contrast-Enhanced Ultrasound. Ultraschall Med, 2015,36(6):594–602
Chatterjee A, Lopes Vendrami C, Nikolaidis P, et al. Uncommon Intraluminal Tumors of the Gallbladder and Biliary Tract: Spectrum of Imaging Appearances. Radiographics, 2019,39(2):388–412
Aslam A, Wasnik AP, Shi J, et al. Intraductal papillary neoplasm ofthe bile duct (IPNB): CT and MRI appearance with radiology-pathology correlation. Clin Imaging, 2020,66:10–17
Liu Y, Zhong X, Yan L, et al. Diagnostic performance of CT and MRI in distinguishing intraductal papillary neoplasm of the bile duct from cholangiocarcinoma with intraductal papillary growth. Eur Radiol, 2015,25(7):1967–1974
Ogawa H, Itoh S, Nagasaka T, et al. CT findings of intraductal papillary neoplasm of the bile duct: assessment with multiphase contrast-enhanced examination using multi-detector CT. Clin Radiol, 2012,67(3):224–231
Ikeno Y, Seo S, Yamamoto G, et al. Usefulness of Preoperative (18)F-FDG-PET in Detecting Invasive Intraductal Papillary Neoplasm of the Bile Duct. Anticancer Res, 2018,38(6):3677–3682
Takanami K, Hiraide T, Kaneta T, et al. FDG PET/CT findings in malignant intraductal papillary mucinous neoplasm of the bile ducts. Clin Nucl Med, 2010,35(2):83–85
Youn JM, Hwang S, Ahn CS, et al. Clinicopathological Features and Long-Term Outcomes of Intraductal Papillary Neoplasms of the Bile Duct of the Liver: Single-Institution Experience with 146 Patients. J Gastrointest Surg, 2022,26(7):1394–1405
Lee S, Kim MJ, Kim S, et al. Intraductal papillary neoplasm of the bile duct: Assessment of invasive carcinoma and long-term outcomes using MRI. J Hepatol, 2019,70(4):692–699
Joo I, Lee JM. Imaging bile duct tumors: pathologic concepts, classification, and early tumor detection. Abdom Imaging, 2013,38(6):1334–1350
Hong GS, Byun JH, Kim JH, et al. Thread sign in biliary intraductal papillary mucinous neoplasm: a novel specific finding for MRI. Eur Radiol, 2016,26(9):3112–3120
Wu CH, Yeh YC, Tsuei YC, et al. Comparative radiological pathological study of biliary intraductal tubulopapillary neoplasm and biliary intraductal papillary mucinous neoplasm. Abdom Radiol (NY), 2017,42(10):2460–2469
Jin KP, Rao SX, Sheng RF, et al. Skewness of apparent diffusion coefficient (ADC) histogram helps predict the invasive potential of intraductal papillary neoplasms of the bile ducts (IPNBs). Abdom Radiol (NY), 2019,44(1):95–103
Jeon SK, Lee JM, Yoo J, et al. Intraductal papillary neoplasm of the bile duct: diagnostic value of MRI features in differentiating pathologic subclassifications-type 1 versus type 2. European radiology, 2023. doi: https://doi.org/10.1007/s00330-023-10491-9. Online ahead of print
Yoon JH. Biliary papillomatosis: correlation of radiologic findings with percutaneous transhepatic cholangioscopy. J Gastrointest Liver Dis, 2013,22(4):427–433
Yeh TS, Tseng JH, Chiu CT, et al. Cholangiographic spectrum of intraductal papillary mucinous neoplasm of the bile ducts. Ann Surg, 2006,244(2):248–253
Chung DJ, Lee SK, Ha HK, et al. Multiple biliary papillomatosis: comparison of MR cholangiography with endoscopic retrograde cholangiography. J Comput Assist Tomogr, 2002,26(6):968–974
Sakamoto E, Hayakawa N, Kamiya J, et al. Treatment strategy for mucin-producing intrahepatic cholangiocarcinoma: value of percutaneous transhepatic biliary drainage and cholangioscopy. World J Surg, 1999,23(10):1038–1043; discussion 1043–1044
Shin IS, Moon JH, Lee YN, et al. Use of peroral cholangioscopy to screen for neoplastic bile duct lesions in patients with bile duct stones (with videos). Gastrointest Endosc, 2021,94(4):776–785
Kalaitzakis E, Webster GJ, Oppong KW, et al. Diagnostic and therapeutic utility of single-operator peroral cholangioscopy for indeterminate biliary lesions and bile duct stones. Eur J Gastroenterol Hepatol, 2012,24(6):656–664
Itoi T, Sofuni A, Itokawa F, et al. Peroral cholangioscopic diagnosis of biliary-tract diseases by using narrow-band imaging (with videos). Gastrointest Endosc, 2007,66(4):730–736
Tsuyuguchi T, Sakai Y, Sugiyama H, et al. Endoscopic diagnosis of intraductal papillary mucinous neoplasm of the bile duct. J Hepatobiliary Pancreat Sci, 2010,17(3):230–235
Lim JH, Jang KT. Mucin-producing bile duct tumors: radiological-pathological correlation and diagnostic strategy. J Hepatobiliary Pancreat Sci, 2010,17(3):223–229
Luvira V, Somsap K, Pugkhem A, et al. Morphological Classification of Intraductal Papillary Neoplasm of the Bile Duct with Survival Correlation. Asian Pac J Cancer Prev, 2017,18(1):207–213
Kubota K, Nakanuma Y, Kondo F, et al. Clinicopathological features and prognosis of mucin-producing bile duct tumor and mucinous cystic tumor of the liver: a multi-institutional study by the Japan Biliary Association. J Hepatobiliary Pancreat Sci, 2014,21(3):176–185
Kim KM, Lee JK, Shin JU, et al. Clinicopathologic features of intraductal papillary neoplasm of the bile duct according to histologic subtype. Am J Gastroenterol, 2012,107(1):118–125
Ying S, Ying M, Liang W, et al. Morphological classification of intraductal papillary neoplasm of the bile duct. Eur Radiol, 2017,28(4):1568–1578
Kim JR, Lee KB, Kwon W, et al. Comparison of the Clinicopathologic Characteristics of Intraductal Papillary Neoplasm of the Bile Duct according to Morphological and Anatomical Classifications. J Korean Med Sci, 2018,33(42):e266
Hucl T. Precursors to Cholangiocarcinoma. Gastroenterol Res Pract, 2019,2019:1389289
Shyu S, Singhi AD. Cystic biliary tumors ofthe liver: diagnostic criteria and common pitfalls. Hum Pathol, 2021,112:70–83
Narita M, Endo B, Mizumoto Y, et al. Multicentric recurrence of intraductal papillary neoplasms of bile duct in the remnant intrahepatic bile duct after curative resection. Int J Surg Case Rep, 2015,12:123–127
Choi JU, Hwang S, Jung DH, et al. Living donor liver transplantation for diffuse biliary papillomatosis with malignant change: A case report with 10-year follow-up. Ann Hepatobiliary Pancreat Surg, 2020,24(2):209–215
Lluís N, Serradilla-Martín M, Achalandabaso M, et al. Intraductal papillary neoplasms of the bile duct: a European retrospective multicenter observational study (EUR-IPNB study). Int J Surg, 2023,109(4):760–771
You Y, Choi SH, Choi DW, et al. Recurrence After Resection for Intraductal Papillary Neoplasm of Bile Duct (IPNB) According to Tumor Location. J Gastrointest Surg, 2020,24(4):804–812
Tang W, Qiu JG, Wei XF, et al. Endoscopic Endoluminal Radiofrequency Ablation and Single-Operator Peroral Cholangioscopy System (SpyGlass) in the Diagnosis and Treatment of Intraductal Papillary Neoplasm of the Bile Duct: A Case Report and Literature Review. Front Med (Lausanne), 2021,8:675720
Arai J, Kato J, Toda N, et al. Long-term survival after palliative argon plasma coagulation for intraductal papillary mucinous neoplasm of the bile duct. Clin J Gastroenterol, 2021,14(1):314–318
Natov NS, Horton LC, Hegde SR. Successful endoscopic treatment of an intraductal papillary neoplasm of the bile duct. World J Gastrointest Endosc, 2017,9(5):238–242
Lee HS, Oh TG, Chung MJ, et al. Photodynamic Therapy Followed by Left Hepatectomy Used to Treat an Intraductal Papillary Mucinous Neoplasm of the Bile Duct. Korean J Med, 2015,88(1):60
Cheong CO, Lim JH, Park JS, et al. Volume-reserving Surgery after Photodynamic Therapy for Biliary Papillomatosis: A Case Report. Korean J Gastroenterol, 2015,66(1):55–58
Kim JR, Jang KT, Jang JY. Intraductal papillary neoplasm of the bile duct: review of updated clinicopathological and imaging characteristics. Br J Surg, 2023,110(9):1229–1240
Uemura S, Higuchi R, Yazawa T, et al. Prognostic Factors for Surgically Resected Intraductal Papillary Neoplasm of the Bile Duct: A Retrospective Cohort Study. Ann Surg Oncol, 2021,28(2):826–834
Luvira V, Pugkhem A, Bhudhisawasdi V, et al. Long-term outcome of surgical resection for intraductal papillary neoplasm of the bile duct. J Gastroenterol Hepatol, 2017,32(2):527–533
Kim WJ, Hwang S, Lee YJ, et al. Clinicopathological Features and Long-Term Outcomes of Intraductal Papillary Neoplasms of the Intrahepatic Bile Duct. J Gastrointest Surg, 2016,20(7):1368–1375
Harada F, Matsuyama R, Mori R, et al. Outcomes of surgery for 2010 WHO classification-based intraductal papillary neoplasm of the bile duct: Case-control study of a single Japanese institution’s experience with special attention to mucin expression patterns. Eur J Surg Oncol, 2019,45(5):761–768
Sasaki M, Matsubara T, Yoneda N, et al. Overexpression of enhancer of zeste homolog 2 and MUC1 may be related to malignant behaviour in intraductal papillary neoplasm of the bile duct. Histopathology, 2013,62(3):446–457
Albores-Saavedra J HD, Klimstra DS. Tumors of the gallbladder, extrahepatic bile ducts, and vaterian system. In. AFIP Atlas of Tumor Pathology. Maryland: American Registry of Pathology.Silver Spring, 2015.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
We declare no conflicts of interest for this article. The corresponding author is responsible for reviewing this policy with all the authors.
Rights and permissions
About this article
Cite this article
Huang, Xh., Chen, Tx., Liu, Hl. et al. A Review of Type 1 and Type 2 Intraductal Papillary Neoplasms of the Bile Duct. CURR MED SCI 44, 485–493 (2024). https://doi.org/10.1007/s11596-024-2863-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-024-2863-5